Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Ultrasound versus auscultation and bronchoscopy for checking double-lumen tube placement

Official title: Ultrasonographic Confirmation of Double-Lumen Endobronchial Tube Placement Compared With Auscultation and Fiberoptic Bronchoscopy in Thoracic Surgery: A Prospective Observational Study

Run by Izmir City Hospital · NCT07465510 · Data updated 2026-11-12

We will test whether bedside lung ultrasound can accurately confirm double-lumen tube placement compared with listening (auscultation) and fiberoptic bronchoscopy in adults having elective thoracic surgery with one-lung ventilation.

More Thoracic Surgery With One-lung Ventilation trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorIzmir City Hospital
Government
Locations1 site (Izmir, İzmir)
StatusRecruiting
StartedJanuary 25, 2026
Main results expectedMay 25, 2026
Study endsJune 15, 2026
Registry record updatedMarch 12, 2026
Trial IDNCT07465510 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 scheduled for elective thoracic surgery with planned one-lung ventilation using a double-lumen endobronchial tube, ASA I–III, who can provide written informed consent are eligible.

Probably not a fit

Patients with airway anomalies, prior lung resection, tracheostomy, coagulopathy, pleural pathology, chest wall deformity, emergency surgery, or who decline participation are excluded and unlikely to benefit from the ultrasound confirmation tested here.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational comparison in adults scheduled for elective thoracic surgery with planned one-lung ventilation using double-lumen endobronchial tubes. After tube placement operators will perform bedside lung ultrasound and standard auscultation, then compare both with fiberoptic bronchoscopy as the reference standard. The study will calculate diagnostic performance measures such as sensitivity, specificity, and predictive values for ultrasound and auscultation. The goal is to see if lung ultrasound can reliably confirm correct DLT position when bronchoscopy is not immediately available.

Why it matters

Potential benefit: If successful, lung ultrasound could offer a rapid, noninvasive bedside method to confirm double-lumen tube position, improving safety when bronchoscopy is unavailable.

How similar studies have gone: Previous investigations have shown promising accuracy for lung ultrasound in confirming lung isolation and tube positioning, but its specific performance for double-lumen tubes is still being refined.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Scheduled for elective thoracic surgery
* Planned one-lung ventilation
* Use of double-lumen endobronchial tube
* ASA physical status I-III
* Written informed consent obtained

Exclusion Criteria:

* Known airway anomalies
* Previous lung resection surgery
* Tracheostomy
* Coagulopathy
* Pleural effusion or pleural pathology that may interfere with lung ultrasound evaluation
* Chest wall deformity
* Emergency surgery
* Patients who decline participation

Where it's running

  • Izmir City Hospital
    Izmir, İzmir, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.